Effect of race on hypertension and antihypertensive therapy

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 2, 2000, Pages 75-79

  Richardson, A D ^a   Piepho, R W ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Antihypertensive drugs; Hypertension; Pharmacotherapy; Race

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; RENIN; TISSUE KALLIKREIN; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CALCIUM INTAKE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG RESPONSE; ETHNIC GROUP; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; KALLIKREIN URINE LEVEL; LIFESTYLE; NEGRO; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; POTASSIUM INTAKE; RACE; SODIUM INTAKE; STROKE;

EID: 0033951656     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38075     Document Type: Article

References (23)

1. Anonymous 1995 Hypertension among Mexican Americans - United States, 1982 - 1984 and 1988 - 1991. MMWR 44: 635-639
2. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P et al 1995a Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension 26: 60-69
3. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M et al 1995b Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988 - 1991. Hypertension 25: 305-313
4. Clark LT 1991 Improving compliance and increasing control of hypertension: needs for special hypertensive populations. Am Heart J 121: 664-669
5. Cooper ES, Kuller LH, Saunders E, Martinez-Maldonado M, Caplan LR, Yatsu FM et al 1991 Cardiovascular diseases and stroke in African Americans and other racial minorities in the United States: a statement for health professionals. Circulation 83: 1464-1480
6. Davis IJ, Grim C, Dwyer K, Nicholson L, Dwyer J 1996 The effects of calcium supplementation on ambulatory blood pressure in African American adolescents. J Ntl Med Assoc 88: 774-778
7. Dwyer JH, Dwyer KM, Scribner RA, Sun P, Li L, Nicholson LM et al 1998 Dietary calcium, calcium supplementation, and blood pressure in African American adolescents. Am J Clin Nutr 68: 648-655
8. Holland OB, Gomez-Sanchez C, Fairchild C, Kaplan NM 1979 Role of renin classification for diuretic treatment of black hypertensive patients. Arch Intern Med 139: 1365-1370
9. Houston MC 1989 New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Am Heart J 117: 911
10. Joint National Committee 1997 The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health publication, pp 98-408 0
11. Jones-Webb R, Jacobs DR, Flack JM, Liu K 1996 Relationships between depressive symptoms, anxiety, alcohol consumption, and blood pressure: results from the CARDIA study. Alcohol Clin Exp Res 20: 420-427
12. Kokkinos PF, Narayan P, Colleran JA, Pittaras A, Notargiacomo A, Reda D et al 1995 Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 333: 1462-1467
13. Krieger N, Sidney S 1996 Racial discrimination and blood pressure: CARDIA Study of young black and white adults. Am J Publ Health 86: 1370-1378
14. Light K, Obrist P, Andrew S 1987 Effects of race and marginally elevated blood pressure on responses to stress. Hypertension 10: 555-563
15. Materson RJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS et al 1993 Single-drug therapy for hypertension in men. N Engl J Med 328: 914-921
16. Messerli FH 1997 Hypertension in special populations. Med Clin North Am 81: 1335-1345
17. Naumburg E, Franks P, Bell B et al 1993 Racial differentials in the identification of hypercholesterolemia. J Fam Pract 36: 425-430
18. Preston RA, Masterson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC et al 1998 Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. JAMA 280: 1168-1172
19. Radevski I, Skudicky D, Candy G. Sathekge S, Strugo V, Sareli P 1999 Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension. Am J Hypertens 12: 194-203
20. Redon J, Lozano JV, de la Figuera M, Roderiguez JC, Garrido J, Ales-Martinez JE et al 1995 Do changes in dietary salt influence blood pressure of hypertensive patients pharmacologically controlled with verapamil? The salt switching study (SSS). J Hum Hypertens 9: 143-147
21. Saunders E 1991 Hypertension in African Americans. Circulation 83: 1465-1467
22. Saunders E, Weir MR, Kong BW, Hollifield J, Gray J, Vertes Vet at 1990 A comparison of the efficacy and safety of β-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 150: 1707-1713
23. 2-receptor-mediated vasodilation in African Americans. Life Sci 57: 1411-1416